Publication Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin resistant leprosy cases. Ahuja M, Singh I, Lavania M, et al. Journal of global antimicrobial resistance. 2022; Download PDF
Publication Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. Andrade E, Brandão J, da Silva J, et al. Antimicrobial agents and chemotherapy. 2022;
Publication Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme. Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022; Download PDF
Publication Interaction of Quinolones Carrying New R1 Group with DNA Gyrase. Park J, Yamaguchi T, Ouchi Y, et al. Microbial drug resistance (Larchmont, N.Y.). 2021; Download PDF
Publication Validação de modelo murino para avaliação da atividade antibacteriana de ofloxacina e clofazimina contra o Mycobacterium leprae Rocha AF. Instituto Lauro de Souza Lima. 2021;
Publication HARP: a database of structural impacts of systematic missense mutations in drug targets of Mycobacterium leprae.. Vedithi S, Malhotra S, Skwark M, et al. Computational and structural biotechnology journal. 2020; Download PDF
Publication Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India. Lavania M, Darlong J, Singh I, et al. Journal of global antimicrobial resistance. 2020; Download PDF
Publication Ofloxacin-Containing Multidrug Therapy in Ambulatory Leprosy Patients: A Case Series. Faust L, Klowak M, MacRae C, et al. Journal of cutaneous medicine and surgery. 2020;
Publication Treatment of histoid leprosy: a lack of consensus. Bartos G, Sheuring R, Combs A, et al. International journal of dermatology. 2020;
Publication Case Report: Multidrug-Resistant Mycobacterium leprae in a Case of Smear-Negative Relapse. Kamat D, Narang T, Ahuja M, et al. The American journal of tropical medicine and hygiene. 2020;
Publication Alternative Leprosy Treatment Using Rifampicin Ofloxacin Minocycline (ROM) Regimen – Two Case Reports Widjaja Y, Djawad K, Amin S, et al. Walter de Gruyter GmbH. Serbian Journal of Dermatology and Venereology. 2019; 11 (3) : 89-93. Download PDF
Publication Development of an Assay System for Genotyping Mycobacterium leprae Resistant to Dapsone, Rifampicin, and Ofloxacin Tanod V, Bela B, Menaldi S, et al. Indian journal of leprosy. 2019; 91 (3) : 185-195. Download PDF
Publication Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-2015. Cambau E, Saunderson P, Matsuoka M, et al. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2018; Download PDF
Publication Interleukin-12 and Interleukin-4 Levels of Multibacillary Leprosy Patients Before and After Rifampicine Ofloxacine Minocycline Combined Therapy Budhiani S, Muchtar SV, Amin S. American journal of clinical and experimental medicine . 2017; 5 (4) : 134-137. Download PDF
Publication Molecular detection of multi drug resistant Mycobacterium leprae from Indian leprosy patients. Lavania M, Singh I, Turankar R, et al. Journal of global antimicrobial resistance. 2017; Download PDF
Publication Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study. Guragain S, Upadhayay N, Bhattarai BM. Clinical pharmacology : advances and applications. 2017; Download PDF
Publication Evaluation of anti-bacterial activity of Rifapentine, Clarithromycin, Minocycline, Moxifloxacin, Ofloxacin and their combinations in Murine Model of Rifampicin Resistant Leprosy Joseph P, Ponnaiya J, Das M, et al. Indian journal of leprosy. 2016; Download PDF
Publication A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India. Kumar A, Girdhar A, Girdhar BK. Indian journal of dermatology, venereology and leprology. 2015; 81 (4) : 356-62. Download PDF
Publication Resistance of M. leprae to Quinolones: A Question of Relativity? Veziris N, Chauffour A, Escolano S, et al. PLOS Neglected Tropical Diseases. 2013; Download PDF
Publication OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil Souza Cunha MG, Virmond M, Schettini AP, et al. Leprosy review. 2012; 83 (3) : 261–268. Download PDF
